The content on this site is intended for healthcare professionals only
The introduction of screening for melanoma has been suggested as a way of increasing early detection rates for myeloma. Some research has indicated that screening for melanoma is expensive and produces relatively small increases in detection, but early results of a large German study have suggested that screening can indeed reduce mortality rates in melanoma. The panel talk about the merits and drawbacks of screening, discuss the importance of education to the prevention of melanoma and explain why education must be targeted at not just the public, but also GPs and people working within the beauty industry.
Best practice in HRRm testing in patients with metastatic prostate cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Community-based breast cancer control programme in the Philipines
Initiatives for cancer control in Indonesia
PHERGain trial ID's early breast cancer cases that benefit from dual HER2 blockade without chemo
Choosing Wisely in radiology Tanzania
Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery
Cancer control in Latin America
Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project
